FR2353551B1 - - Google Patents

Info

Publication number
FR2353551B1
FR2353551B1 FR7717086A FR7717086A FR2353551B1 FR 2353551 B1 FR2353551 B1 FR 2353551B1 FR 7717086 A FR7717086 A FR 7717086A FR 7717086 A FR7717086 A FR 7717086A FR 2353551 B1 FR2353551 B1 FR 2353551B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7717086A
Other languages
French (fr)
Other versions
FR2353551A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH703976A external-priority patent/CH625240A5/it
Priority claimed from CH704076A external-priority patent/CH625241A5/it
Application filed by Individual filed Critical Individual
Publication of FR2353551A1 publication Critical patent/FR2353551A1/fr
Application granted granted Critical
Publication of FR2353551B1 publication Critical patent/FR2353551B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D461/00Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR7717086A 1976-06-03 1977-06-03 Nouveaux derives de la vincamine et de l'apovincamine, leur procede de preparation et leur utilisation dans le traitement des affections circulatoires, cerebrales et cardiovasculaires Granted FR2353551A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH703976A CH625240A5 (en) 1976-06-03 1976-06-03 Process for preparing novel derivatives of vincamine and apovincamine
CH704076A CH625241A5 (en) 1976-06-03 1976-06-03 Process for preparing novel salts of vincamine and apovincamine

Publications (2)

Publication Number Publication Date
FR2353551A1 FR2353551A1 (fr) 1977-12-30
FR2353551B1 true FR2353551B1 (US06174465-20010116-C00003.png) 1980-12-12

Family

ID=25700616

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7717086A Granted FR2353551A1 (fr) 1976-06-03 1977-06-03 Nouveaux derives de la vincamine et de l'apovincamine, leur procede de preparation et leur utilisation dans le traitement des affections circulatoires, cerebrales et cardiovasculaires

Country Status (11)

Country Link
US (1) US4122179A (US06174465-20010116-C00003.png)
JP (1) JPS52151715A (US06174465-20010116-C00003.png)
AU (1) AU514744B2 (US06174465-20010116-C00003.png)
CA (1) CA1085827A (US06174465-20010116-C00003.png)
DE (1) DE2725246A1 (US06174465-20010116-C00003.png)
ES (1) ES459423A1 (US06174465-20010116-C00003.png)
FR (1) FR2353551A1 (US06174465-20010116-C00003.png)
GB (1) GB1549501A (US06174465-20010116-C00003.png)
IE (1) IE790258L (US06174465-20010116-C00003.png)
IT (1) IT1074400B (US06174465-20010116-C00003.png)
NL (1) NL7706046A (US06174465-20010116-C00003.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1117939A (en) * 1978-02-15 1982-02-09 Enrico C. Mora Derivatives of eburnamomine and related method of manufacturing
US4362730A (en) * 1980-08-25 1982-12-07 Heinrich Mack Nachf. Chem-Pharm. Fabrik Vincamine saccharinate and a pharmaceutical composition containing it dissolved therein
DE3113132A1 (de) * 1981-04-01 1982-10-21 Heinrich Mack Nachf., 7918 Illertissen Vincamin-cyclamat, verfahren zu seiner herstellung und dieses enthaltende arzneimittel
DE3479423D1 (en) * 1984-02-29 1989-09-21 Covex Sa Citrate of vinpocetine, and process for its preparation
US5506210A (en) * 1988-08-19 1996-04-09 The Australian National University Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs
DE68926746T2 (de) * 1988-08-19 1996-11-28 Univ Australian Auf phosphozucker basierende antientzündliche und/oder immunitätsunterdrückende arzneimittel
DE4011285A1 (de) * 1990-04-06 1991-10-10 Steigerwald Arzneimittelwerk Arzneimittel zur behandlung von hyperlipidaemie und/oder atherosklerose
US20050032710A1 (en) * 2003-05-16 2005-02-10 Kao Corporation Alternative agent with vitamin D-like activity and an improving agent for intestinal function
JP4485169B2 (ja) * 2003-05-16 2010-06-16 花王株式会社 腸管ミネラル吸収能改善剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3450814A (en) * 1964-07-15 1969-06-17 Chemway Corp Ophthalmic compositions containing alginic acid salts of pilocarpine,atropine and physostigmine
FR2155889A1 (en) * 1971-10-13 1973-05-25 Buzas Andre Vincamine theophyllinepropanesulphonate - with cerebral vasodilatory activity
BE790837A (fr) * 1971-11-03 1973-02-15 Richter Gedeon Vegeon Vegyesze Nouveaux esters alcaloides utiles comme vasodilatateurs cerebraux et leur procede de preparation
FR2179538B1 (US06174465-20010116-C00003.png) * 1972-04-11 1975-04-25 Merrell Toraude & Co
FR2191891B1 (US06174465-20010116-C00003.png) * 1972-07-13 1975-08-08 Roussel Uclaf
FR2201898A1 (en) * 1973-05-30 1974-05-03 Sogeras Vincamine arabogalactan sulphate - with prolonged activity for treating cerebrovascular disorders
FR2255885B1 (US06174465-20010116-C00003.png) * 1973-12-28 1977-09-09 Centre Etd Ind Pharma
CH585226A5 (en) * 1974-03-08 1977-02-28 Vifor Sa Slightly soluble vincamine pamoates - with long duration of action as cerebral vasodilators
FR2274283A1 (fr) * 1974-06-12 1976-01-09 Castaigne Sa Nouveau sel de vincamine
FR2283669A1 (fr) * 1974-09-06 1976-04-02 Elmu Sa 2-cetoglutarate de vincamine et son procede de preparation
ES430059A1 (es) * 1974-09-14 1976-10-16 Roger Lab Procedimiento para la obtencion de un nuevo derivado del a-cido nicotinico.

Also Published As

Publication number Publication date
AU514744B2 (en) 1981-02-26
IT1074400B (it) 1985-04-20
DE2725246A1 (de) 1977-12-22
ES459423A1 (es) 1978-11-01
CA1085827A (en) 1980-09-16
DE2725246C2 (US06174465-20010116-C00003.png) 1989-09-07
NL7706046A (nl) 1977-12-06
IE790258L (en) 1979-08-15
AU2579777A (en) 1978-12-07
FR2353551A1 (fr) 1977-12-30
JPS52151715A (en) 1977-12-16
GB1549501A (en) 1979-08-08
US4122179A (en) 1978-10-24

Similar Documents

Publication Publication Date Title
DK212977A (US06174465-20010116-C00003.png)
DK142252C (US06174465-20010116-C00003.png)
DE2714346C3 (US06174465-20010116-C00003.png)
DK140653C (US06174465-20010116-C00003.png)
DK142676C (US06174465-20010116-C00003.png)
DE2732896C2 (US06174465-20010116-C00003.png)
DE2615739C2 (US06174465-20010116-C00003.png)
DK142582C (US06174465-20010116-C00003.png)
JPS532450U (US06174465-20010116-C00003.png)
DK139493C (US06174465-20010116-C00003.png)
DE2637745C2 (US06174465-20010116-C00003.png)
JPS52147450U (US06174465-20010116-C00003.png)
JPS52152709U (US06174465-20010116-C00003.png)
CS175508B1 (US06174465-20010116-C00003.png)
CH606668A5 (US06174465-20010116-C00003.png)
CH614800A5 (US06174465-20010116-C00003.png)
CH594511A5 (US06174465-20010116-C00003.png)
CH598074A5 (US06174465-20010116-C00003.png)
CH598256A5 (US06174465-20010116-C00003.png)
CH600792A5 (US06174465-20010116-C00003.png)
CH602320A5 (US06174465-20010116-C00003.png)
CH605017A5 (US06174465-20010116-C00003.png)
CH605143A5 (US06174465-20010116-C00003.png)
CH606592A5 (US06174465-20010116-C00003.png)
CH575859A5 (US06174465-20010116-C00003.png)

Legal Events

Date Code Title Description
ST Notification of lapse